A New Roadmap for Drug Development for Alzheimer's Disease

Nature Reviews Drug Discovery - United Kingdom
doi 10.1038/nrd3842-c2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Drug Development for Alzheimer's Disease: Recent Progress

Experimental Neurobiology
Molecular NeuroscienceNeurologyCellular
2010English

The Cell Cycle Hypothesis of Alzheimer's Disease: Suggestions for Drug Development

Biochimica et Biophysica Acta - Molecular Basis of Disease
Molecular MedicineMolecular Biology
2007English

Drug Development for Alzheimer's Disease: Where Are We Now and Where Are We Headed?

The American Journal of Geriatric Pharmacotherapy
2009English

Emerging Drug Targets for Aβand Tau in Alzheimer's Disease: A Systematic Review

British Journal of Clinical Pharmacology
Pharmacology
2015English

Selecting for Neurogenic Potential as an Alternative for Alzheimer's Disease Drug Discovery

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2016English

Myeloperoxidase: A Target for New Drug Development?

British Journal of Pharmacology
Pharmacology
2007English

Scientists Propose a New Theory for the Pathogenesis of Alzheimer's Disease

BMJ
2001English

Biomarkers for Alzheimer's Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2006English

Commentary on “Biomarkers in Alzheimer's Disease Drug Development.” Can't Live Without ‘Em

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy